跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INQOVI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INQOVI
Authorized
STANDARD
INQOVI
taiho pharma canada, inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
79ccb20806d2d61b
Company
taiho pharma canada, inc.
Type
Standard
Approval Details
Approval Id
79ccb20806d2d61b
Drug Approval Canada Name
INQOVI
Product Name
INQOVI
Status
Marketed
Status Date
2025-06-04
Original Market Date
2020-11-11
Din
02501600
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC58 DECITABINE, COMBINATIONS
Atc Name
l 01 bc 58
Aig Number
0262355001
Company Name
taiho pharma canada, inc.
Company Address
503, 2010 Winston Park Drive, Oakville, Ontario, Canada, L6H 5R7
Active Ingredients
CEDAZURIDINE
100 MG
DECITABINE
35 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
79ccb20806d2d61b
Type
Standard
Back to Health Canada Approvals